Contract Analytical Services

Meeting E&L Expectations

December 02, 2019

As regulatory bodies extend the oversight of E&L testing, companies working with drug products need to make provisions on how to best comply with the evolving expectations.

Thermo Fisher Scientific Expands Capabilities

November 22, 2019

New training facilities, laboratories, packaging, gene therapy manufacturing, and biologics manufacturing highlight Thermo Fisher Scientific expansions.

Pharma Contract Market Update

August 02, 2019

CMOs and CDMOs expanded their services and facilities in the summer of 2019.

Designing Phase-Appropriate CMC Analytical Programs

August 01, 2019

A one-size-fits-all strategy is not the best approach for the development of a chemistry, manufacturing, and controls program.

De-risking Biologics Development Through Advanced Mass Spectrometry Approaches

August 01, 2019

Using advanced HDX-MS and native MS techniques can improve the identification of potentially successful biologic drugs and de-risk CMC and clinical designs.

Best Practices for Selecting a Service Provider

August 01, 2019

Key considerations when searching for an analytical service provider include workflow, hardware, and regulatory support.

Cambrex Announces Expansion of Scottish Solid-Form Screening Facility

July 30, 2019

Cambrex has revealed that it is expanding its solid form screening and crystallization process development facility in Edinburgh, Scotland.

Cytel, Axio Unite for Analytical Solutions

June 13, 2019

The companies will form a biometrics organization focused on delivering analytical solutions for drug development.

Aptar Acquires Nanopharm and Gateway Analytical

June 13, 2019

Pharmaceutical Technology's In the Lab eNewsletter

The acquisitions, totaling $50 million, are expected expand Aptar Pharma’s service offerings to support complex product development.

SGS Acquires Chemical Solutions

May 07, 2019

The acquisition is expected to strengthen SGS’s agriculture, food, and life business in the United States.